Numerous studies have demonstrated overexpressed MMP-2 in various tumours: breast cancer [22–27], lung cancer [28], colorectal tumours [29], gastric and esophageal cancers [31–35], and pancreatic carcinoma [30]. Here, MMP2 is linked to esophageal cancer.